ABT-869
Product Specifications
Background
ABT-869 (796967-16-3) ia a structurally novel, potent inhibitor of receptor tyrosine kinases inhibiting VEGFR and PDGFR and related kinases with IC50s= 3, 4, 4, 66, 3 and 14 nM for VEGFR1, VEGFR2, FLT3, PDGFRβ, CSF-1R and KIT respectively.1,2 Protects cells from necroptosis and rescues SIRS mice from TNF-α-induced shock and death.3 Exerts anti-obesity effects by promoting adipocyte browning.4 Inhibits angiogenesis.5
Conjugation
Unconjugated
Buffer
Off-white solid
Storage Conditions
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
YLA1306HU-01 48 Tests
Human Metastasis-associated protein MTA1 (MTA1) ELISA Kit
Sign In for Pricing
View Details YLA1306HU-02 96 Tests
Human Metastasis-associated protein MTA1 (MTA1) ELISA Kit
Sign In for Pricing
View Details